A Randomized, Double-blind Controlled Clinical Study to Evaluate the Efficacy and Safety of Minoxidil Topical 2% Nanosuspension with Aqueous Base in the Treatment of Androgenetic Alopecia Areata

Shahla Mirzaeei; Ashkan Barfar; Saba Mehrandish; Ali Ebrahimi

doi:10.4103/jrptps.JRPTPS_25_21

Outlines

Abstract
Copyright

https://doi.org/10.4103/jrptps.JRPTPS_25_21

A Randomized, Double-blind Controlled Clinical Study to Evaluate the Efficacy and Safety of Minoxidil Topical 2% Nanosuspension with Aqueous Base in the Treatment of Androgenetic Alopecia Areata

Author(s):

Shahla Mirzaeei

^{1, 1,*},

Ashkan Barfar²,

Saba Mehrandish

²,

Ali Ebrahimi³

1Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

2Student Research Committee, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

3Dermatology Department, Kermanshah University of Medical Sciences, Kermanshah, Iran

Journal of Reports in Pharmaceutical Sciences:Vol. 10, issue 2; 279-86

Published online:Dec 17, 2021

Article type:Research Article

Received:Feb 20, 2021

Accepted:May 29, 2021

How to Cite:Mirzaeei S, Barfar A, Mehrandish S, Ebrahimi A. A Randomized, Double-blind Controlled Clinical Study to Evaluate the Efficacy and Safety of Minoxidil Topical 2% Nanosuspension with Aqueous Base in the Treatment of Androgenetic Alopecia Areata. J Rep Pharm Sci. 2021;10(2):e146965. doi: https://doi.org/10.4103/jrptps.JRPTPS_25_21

Abstract

Background and Purpose: Using the commercially manufactured forms of minoxidil, the only approved topical drug preparation for hair regrowth in patients with androgenetic alopecia (AGA) comes across with challenges such as limited permeation through the superficial layers of the skin to reach the site of action and topical adverse reactions like itching and inflammation occur because of the ethanol in the formulations. In this study, a novel nanosuspension formulation with an aqueous base was prepared and evaluated to overcome the discussed challenges.
Materials and Methods: The nanosuspension formulation was characterized by size, zeta potential, morphology, and in vitro release. Seventy patients were subjected to use either 1 mL of nanosuspension or the commercial product twice daily for six months and were then examined for changes in hair follicle diameter and hair density within a 1 × 1-cm2 area of the scalp as the primary endpoints besides any adverse reaction manifestation as the secondary endpoint.
Results: The nanosuspension formulation showed uniform morphology, 200-nm particle size, and suitable zeta potential that ensures the stability. The in vitro release study exhibited almost 90% release in the first 6 h. It was observed that there were no significant differences between the efficacy of aqueous-based topical 2% nanosuspension of minoxidil and the commercial product in the treatment of AGA (P > 0.05). However, the aqueous-based topical 2% nanosuspension formulation showed better safety and tolerability compared to the marketed profile.
Conclusions: It could be concluded that aqueous-based topical 2% nanosuspension is a suitable form with enhanced patient compliance compared to commercially manufactured products.

Keywords

Androgenetic alopecia areata

clinical study

minoxidil

nanosuspension

Topical Turmeric Microemulgel in the Management of Plaque Psoriasis; A Clinical Evaluation

Mehdi Rajabi

Rajabi M. Topical Turmeric Microemulgel in the Management of Plaque Psoriasis; A Clinical Evaluation. Iran J Pharm Res. 2015;14(3):e125302. doi: https://doi.org/10.22037/ijpr.2015.1724

20

Nov

2010

Formulation and In Vitro Evaluation of Silver Sulfadiazine Spray

Seyed Mohsen Foroutan,

Hossein-Ali Ettehadi,

Hamid Reza Torabi

Foroutan SM, Ettehadi H, Torabi HR. Formulation and In Vitro Evaluation of Silver Sulfadiazine Spray. Iran J Pharm Res. 2002;1(1):e127585. doi: https://doi.org/10.22037/ijpr.2010.9

30

Dec

2024

Efficacy of a Herbal Cream Formulation Incorporating Calendula officinalis, Glycyrrhiza glabra, Curcuma longa, and Fumaria parviflora Versus Topical Mometasone in the Management of Atopic Dermatitis

Fariba Iraji,

Behzad Zolfaghari,

Azam Mousavi,

Faeze Mousavi

Iraji F, Zolfaghari B, Mousavi A, Mousavi F. Efficacy of a Herbal Cream Formulation Incorporating Calendula officinalis, Glycyrrhiza glabra, Curcuma longa, and Fumaria parviflora Versus Topical Mometasone in the Management of Atopic Dermatitis. J Skin Stem Cell. 2024;11(4):e157540. doi: https://doi.org/10.5812/jssc-157540

31

Jan

2021

Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-blind, Placebo-controlled, Clinical Trial

Ali Asilian,

Farahnaz Fatemi,

Zakiye Ganjei,

Amir Hossein Siadat,

Fatemeh Mohaghegh,

Mansour Siavash

Asilian A, Fatemi F, Ganjei Z, Siadat AH, Mohaghegh F, et al. Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-blind, Placebo-controlled, Clinical Trial. Iran J Pharm Res. 2021;20(1):e124354. doi: https://doi.org/10.22037/ijpr.2020.113868.14536

31

Oct

2014

Preparation, Characterization and Stability Study of Dutasteride Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy

Mohammad Sajid Ali,

Mohammad Sarfaraz Alam,

Nawazish Alam,

Masoom Raza Siddiqui

Ali MS, Alam MS, Alam N, Siddiqui MR. Preparation, Characterization and Stability Study of Dutasteride Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy. Iran J Pharm Res. 2014;13(4):e125572. doi: https://doi.org/10.22037/ijpr.2014.1563

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 1
Last Update: 2 weeks ago
Scopus by Title: 1
Last Update: 2 weeks ago
Scopus by Title (Ref): 1
Last Update: 2 weeks ago
CrossRef: 3
Last Update: 2 days ago

Metrics

Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Shahla Mirzaeei:[PubMed][Scholar]
Ashkan Barfar:[PubMed][Scholar]
Saba Mehrandish:[PubMed][Scholar]
Ali Ebrahimi:[PubMed][Scholar]

Outlines

A Randomized, Double-blind Controlled Clinical Study to Evaluate the Efficacy and Safety of Minoxidil Topical 2% Nanosuspension with Aqueous Base in the Treatment of Androgenetic Alopecia Areata

Abstract

Similar Articles

Topical Turmeric Microemulgel in the Management of Plaque Psoriasis; A Clinical Evaluation

Formulation and In Vitro Evaluation of Silver Sulfadiazine Spray

Efficacy of a Herbal Cream Formulation Incorporating Calendula officinalis, Glycyrrhiza glabra, Curcuma longa, and Fumaria parviflora Versus Topical Mometasone in the Management of Atopic Dermatitis

Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-blind, Placebo-controlled, Clinical Trial

Preparation, Characterization and Stability Study of Dutasteride Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy

Crossmark

Checking

Last Update: 2 weeks ago

Last Update: 2 weeks ago

Last Update: 2 weeks ago

Last Update: 2 days ago